Literature DB >> 33486103

Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation.

Astrid Bergbreiter1, Teresa Jaeger1, Antje Karle2, Diane Bitzinger2, Tobias Ettl3, Gerrit Spanier3, Herbert Jägle4, Reiner Neu5, Yorick Söder6, Matthias Evert7, Torsten E Reichert3, Mark Berneburg1, Christoph Brochhausen7, Julia Schreml8, Manfred Fliegauf9, Ulrich Salzer9, Andreas Redel10, Stephan Schreml11.   

Abstract

BACKGROUND: Mutations in NFKB1(nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) are associated with a variety of clinical symptoms, including lymphadenopathy, splenomegaly, hepatomegaly, autoimmune haemolytic anaemia, arthralgia, recurrent respiratory tract infections and post-operative necrotizing cellulitis. CASE
PRESENTATION: We describe a case of a 47-year-old man, who presented with deep necrotizing cellulitis after incision of a submucous abscess by a dentist. Surgical intervention led to a massive progress. Pyoderma gangraenosum (PG) was diagnosed clinically and confirmed histopathologically. High dose corticosteroids and intravenous immunoglobulins (IVIG) improved wound healing dramatically. Until now, immune mediated inflammation events not only affected the skin, but also multiple inner organs, i.e. the heart, lungs and gut. Sequencing of all coding exons of NFKB1 revealed a heterozygous 1bp deletion in exon 23 predicting a frameshift starting at codon Ala891 and resulting in a subsequent stop codon at position 6 in the new reading frame: NM_003998.4: c.2671del; p.(Ala891Glnfs*6) Acute episodes were always successfully treated with corticosteroids, IVIG and concomitant antibiotics. To prevent further exacerbations, the patient receives IVIG once a month, low-dose corticosteroids and methotrexate.
CONCLUSION: This is the first case of a patient with recurrent necrotizing cellulitis and immune mediated multi-organ involvement (heart, lungs, intestine) carrying the novel frameshift mutation c.2671del (p.Ala891Glnfs*6) in NFKB1 effectively treated with IVIG, low-dose corticosteroids and methotrexate.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Immune mediated disorders; Immunodeficiency; Immunoglobulins; NFKB1; Necrotizing cellulitis; Pyoderma gangraenosum

Mesh:

Substances:

Year:  2021        PMID: 33486103     DOI: 10.1016/j.ejmg.2021.104144

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

1.  Case Report: Post-Partum Complications of NFκB1 Deficiency Underscore a Need to Better Understand Primary Immunodeficiency Management During Pregnancy.

Authors:  Diem-Tran I Nguyen; Amanda Grimes; Donald Mahoney; Sebastian Faro; William T Shearer; Aaron L Miller; Nicholas L Rider
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

2.  Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study.

Authors:  Jessica Rojas-Restrepo; Andrés Caballero-Oteyza; Katrin Huebscher; Hanna Haberstroh; Manfred Fliegauf; Baerbel Keller; Robin Kobbe; Klaus Warnatz; Stephan Ehl; Michele Proietti; Bodo Grimbacher
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

3.  Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50.

Authors:  Manfred Fliegauf; Matias Kinnunen; Sara Posadas-Cantera; Nadezhda Camacho-Ordonez; Hassan Abolhassani; Laia Alsina; Faranaz Atschekzei; Delfien J Bogaert; Siobhan O Burns; Joseph A Church; Gregor Dückers; Alexandra F Freeman; Lennart Hammarström; Leif Gunnar Hanitsch; Tessa Kerre; Robin Kobbe; Svetlana O Sharapova; Kathrin Siepermann; Carsten Speckmann; Sophie Steiner; Nisha Verma; Jolan E Walter; Emma Westermann-Clark; Sigune Goldacker; Klaus Warnatz; Markku Varjosalo; Bodo Grimbacher
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.